Telogen effluvium is temporary hair loss that occurs due to stress, shock, or a traumatic event. It is seen on the top of the scalp. A major characteristic of telogen effluvium is increased shedding or thinning of a person’s hair.
Telogen Effluvium Treatment Market: Introduction
- Telogen effluvium is temporary hair loss that occurs due to stress, shock, or a traumatic event. It is seen on the top of the scalp. A major characteristic of telogen effluvium is increased shedding or thinning of a person’s hair.
- Chronic telogen effluvium is observed when a person experience periods of hair shedding for more than 6 months. The person may not lose all the hair but might notice thinning of hair.
- The condition is mostly seen in women, primarily triggered by disturbance in normal hair cycle. Telogen effluvium occurs in telogen or resting phase, last phase of hair cycle after anagen or growth phase and catagen or transitional phase.
- In people suffering from telogen effluvium, the anagen phase slows down, with very few hair entering the next two stages and subsequently, resulting in hair loss
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78509
Key Drivers of Global Telogen Effluvium Treatment Market
- The global telogen effluvium treatment market is primarily driven by a rise in the number of people with telogne effluvium. Additionally, lifestyle changes such as improper diet habits, increase stress, lack of sleep, and increased intake of tobacco and alcohol are projected to boost the market during the forecast period.
- Increase in disposable income, rise in emphasis on esthetics, appearance, and beauty among women and rise in awareness about hair loss are projected to drive the global market during the forecast period
Request for Analysis of COVID-19 Impact on Telogen Effluvium Treatment Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78509
Nutritional supplements segment to account for major share of global telogen effluvium market
- In terms of product, the global telogen effluvium treatment market can be classified into nutritional supplements, medications, shampoos and conditioners, and others
- The nutritional supplements segment is anticipated to dominate the global market during the forecast period, due to an increase in availability of nutritional supplements for hair loss and exponential increase number of patients experiencing hair loss
- Viviscal is a company that offers scientifically formulated dietary supplements for hair growth. The company’s products include Biotin, Apple Extract, and Vitamin C.
Dermatology clinics to be highly lucrative segment
Based on end-user, the global telogen effluvium treatment market can be categorized into homecare, dermatology clinics, and others
The dermatology clinics segment is likely to account for a major share of the global telogen effluvium treatment market by 2030. Expansion of the segment is projected to be driven by a significant increase in the number of dermatology clinics, availability of well-qualified & trained dermatologists, and a rise in the number of patients with hair loss issues.
Pre book Telogen Effluvium Treatment Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=78509<ype=S
North America to dominate global telogen effluvium treatment market
- In terms of region, the global telogen effluvium treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global telogen effluvium treatment market during the forecast period.
- The market in North America is anticipated to be driven by the dramatic rise in hair loss issues among youth, unhealthy lifestyles, increase in research & development about treatment options for telogen effluvium, and wide range of hair fall solutions available in the market in the region
- According to data gathered by the American Hair Loss Association, in the U.S., nearly two-thirds of men would have some degree of hair loss by the age of 35, and nearly 85% of men are likely to experience significant hair thinning by the age of 50.
Read More Information: https://www.transparencymarketresearch.com/telogen-effluvium-treatment-market.html
Key Players Operating in Global Telogen Effluvium Treatment Market
The global Telogen Effluvium Treatment market is highly fragmented, with a large number of domestic players accounting for a major share of the market. Key players operating in the global Telogen Effluvium Treatment market are:
- Hims, Inc
- Viviscal
- Cipla
- Ultrax Labs
- Nutraceutical Wellness Inc.
- Vitabiotics
- Dr. Reddy’s Laboratories Ltd.
- Merck & Co., Inc.
- Regaine
- Ranbaxy Laboratories Ltd
- Phyto - Alès Groupe
- Rogaine - Johnson and Johnson.
- Kirkland Signature
- Nanogen
- Alpecin - Dr. Kurt Wolff GmbH & Co. KG
Browse More Trending Reports by Transparency Market Research:
Formalin-Fixed Paraffin-Embedded (FFPE) tissue samples have been a staple of research and therapeutic applications for several years. FFPE is a form of preservation and preparation for biopsy samples that aid in the diagnosis, experimental research, and drug development. A tissue sample is first preserved by fixing it in formaldehyde, commonly known as formalin, to store the proteins and vital structures within the tissue. Moreover, it is embedded in a paraffin wax block that makes it easier to cut slices of required measurements to install on a microscopic slide for analysis. Furthermore, the growing workload of histopathologists can be attributed to a large number of samples of increasing complexity in an era of personalized medicine. This is most likely to improve demand for the FFPE tissue samples market during the forecast period.
A Holter ECG monitor continuously tracks various electrical activities of the cardiovascular system and records electrocardiogram (ECG) of arrhythmia patients. It is also used to detect conduction block in auricles and ventricles. Increase in the number of cases of arrhythmia and conduction block is the major factor driving the global Holter ECG monitor market. Rise in adoption of Western lifestyle and dietary pattern in developing countries in Southeast Asia and Latin America has increased the prevalence of cardiac disorders in these regions, leading to surge in demand for Holter ECG monitor devices.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453